[Effect of livex on hypochromic anemia].
Livex is a lyophilised preparation of the bovine blood which contains 70% of proteins and 0.3% of iron. Livex was given to 25 patients with iron deficiency anemia (group I), and 25 patients with lymphoreticular malignancies accompanied by iron deficiency with or without anemia. The dose was 5 g t.i.d. for 3 months. The majority of patients of group I were women. Excessive menstrual bleeding and chronic gastritis were most common causes of iron deficiency in this group. Livex statistically significantly increased hemoglobin, hematocrit, corrected reticulocyte count, mean erythrocyte hemoglobin, serum iron, percent transferrin saturation, and leukocyte count. Therapy produced significant increase in serum iron, total iron binding capacity, and percent transferrin saturation in patients with lymphoreticular malignancies.
Nowicka
J
J
Kliniki Hematologii AM we Wrocławiu.
Kuliszkiewicz-Janus
M
M
Fischer
W
W
D000328:Adult; D000747:Anemia, Hypochromic / Q000097:blood / Q000628:therapy*; D001798:Blood Proteins / Q000494:pharmacology*; D004044:Dietary Proteins / Q000494:pharmacology*; D004906:Erythrocyte Count; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007501:Iron / Q000097:blood; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D010952:Plasma Substitutes / Q000627:therapeutic use*
D001798:Blood Proteins; D004044:Dietary Proteins; D006454:Hemoglobins; C084915:Livex; D010952:Plasma Substitutes; D007501:Iron
Wpływ livexu na niedokrwistość z niedoboru zelaza.